Portfolio and pipeline
Multiparticulate pellet formulations.
Semi-finished, ready-to-fill pellet dosage forms. Search by molecule, or separate commercial manufacture from the development pipeline.
Loading the portfolio…
Portfolio and pipeline
Semi-finished, ready-to-fill pellet dosage forms. Search by molecule, or separate commercial manufacture from the development pipeline.
Loading the portfolio…
Showing 9 validated formulations
Active Molecule: Itraconazole
Immediate-release pellets of Itraconazole layered onto neutral starter sugar spheres with a protective seal coating for capsule filling.
Validated drug load
22.5% w/w
Standards: IP · USP · BP
Active Molecule: Domperidone
Immediate-release pellets formulated for prompt drug dissolution, suitable for capsule filling or multi-component combination capsule fills.
Validated drug load
10.0% w/w
Standards: IP · BP
Active Molecule: Atorvastatin
Immediate-release pellets containing Atorvastatin, formulated with protective barrier coating for capsule filling.
Validated drug load
10.0% w/w
Standards: IP · USP · BP
Active Molecule: Clopidogrel
High drug-load (50% w/w) immediate-release antiplatelet multiparticulates layered onto neutral starter cores for capsule filling.
Validated drug load
50.0% w/w
Standards: IP · USP · BP
Active Molecule: Rosuvastatin
Immediate-release pellets containing Rosuvastatin, layered with protective coatings to maintain active substance stability and batch content uniformity.
Validated drug load
10.0% & 7.5% w/w
Standards: IP
Active Molecule: Dabigatran Etexilate Mesylate
Immediate release multiparticulate pellets under development pipeline.
Validated drug load
35.0% & 40.0% w/w
Standards: USP / In-house
Active Molecule: Orlistat
Immediate release pellets under development pipeline.
Validated drug load
25.0% & 50.0% w/w
Standards: USP Candidate
Active Molecule: Chlorpheniramine Maleate
Antihistamine multiparticulates formulated for combination products under development.
Validated drug load
4.0% w/w
Standards: IP Candidate
Active Molecule: Sucralfate
High drug-load immediate release pellets under development pipeline.
Validated drug load
70.0% w/w
Standards: USP / IP Candidate